Ireland and the Netherlands have joined the list of countries that have suspended the use of AstraZeneca’s Covid vaccine because of fears over blood clotting. The Dutch Government has announced a suspension until at least March 29th. Both countries have paused their rollout efforts due to reports of “bleeding, blood clots and a low count of blood platelets” in health workers who had recently received the vaccine.
The Republic of Ireland’s Deputy Chief Medical Officer acknowledged in a statement that “it has not been concluded that there is any link between the Covid vaccine AstraZeneca and these cases [of clotting]”.
However, acting on the precautionary principal, and pending receipt of further information, the NIAC (National Immunisation Advisory Committee) has recommended the temporary deferral of the Covid vaccine AstraZeneca vaccination programme in Ireland.
The NIAC is due to meet again this morning. A further statement will follow thereafter.
AstraZeneca addressed these safety concerns in a statement issued at 6pm last night.
A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with Covid Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country.
So far across the EU and UK, there have been 15 events of DVT and 22 events of pulmonary embolism reported among those given the vaccine, based on the number of cases the Company has received as of 8 March. This is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines. …
Furthermore, in clinical trials, even though the number of thrombotic events was small, these were lower in the vaccinated group. There has also been no evidence of increased bleeding in over 60,000 participants enrolled.
One particular batch of AstraZeneca vaccines (which is involved in reports of a death) was sent to 17 countries, an increasing number of which are putting the rollout of this vaccine on hold.
Stop Press: Health officials in Northern Ireland have announced that they will continue to use the Oxford-AstraZeneca vaccine after its suspension in the Republic of Ireland.
To join in with the discussion please make a donation to The Daily Sceptic.
Profanity and abuse will be removed and may lead to a permanent ban.
So if you don’t like the mRNA vaccines you have “general vaccine scepticism”? What kind of sceptics website is this? mRNA treatments have nothing to do with any vaccines I’ve had. They are a form of gene therapy.
This is what comes of just quoting an MSM article verbatim, rather than doing any sceptical journalism.
The European hesitancy and precautionary principle means that their countries will be in totalitarian lockdown for years to come. It will never be safe enough to do anything for a great many people. Somebody might catch a bad cold.
Let’s hope Britain doesn’t follow them down that path. The problem with the success of flu vaccinations is that very few younger people have ever had the full fortnight of flu or anything else really serious and have no idea how bad it feels – or how it feels to recover from such an illness.
Which makes Covid, at two or three times as bad as a nasty flu, very scary indeed, particularly when people are filming themselves looking like they are at death’s door on day 10 – just before they start to get better.
“Covid, at two or three times as bad as a nasty flu,”
That’s true of the fatality overall, but for most people under 65, flu is two or three times as bad as Covid, given the differences in the shapes of the fatality curves. The risk of death from Covid if you are under 65 is something like 5 in 10,000.
As for the precautionary principle being adopted by some of the European nations’ drug regulators – I’d like to see a bit more of that here. Seems to me they are doing the job the UK MHRA should be doing – protecting their public against hastily introduced pharmaceutical products which are starting to exhibit alarming symptoms of causing injuries and deaths in young, healthy people.
Of course it would be nice to see them investigating the Pfizer vaccine as rigourously as the AZ one, but I am sure that time will come.
A bit surprised that this document is not highlighted.You have to be very careful just quoting MSM and indeed any verbal communication from EMA as circulated.If you check this written report it is now a safety signal,The whole discussion is about a specific syndrome now very suspect,which has also got a namne VIPIT(Vaccine induced protrombin immune thrombocytopenia).As the article says nothig to do with common thrombosis now peddling around by MSM.How common is this? Nobody knows but in Norway 1 in 15000 vaccine doses had this syndrome and died.Norway will decide today but please report on ATL also on published document that this is not a wild scare from antivaxxer but being “upgraded” even by EMA as a safety signal.
https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-update-ongoing-evaluation-blood-clot-casesCOVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
“The review of thromboembolic events with COVID-19 Vaccine AstraZeneca is being carried out in the context of as afety signal under an accelerated timetable. A safety signal is information on a new or incompletely documented adverse event that is potentially caused by a medicine such as a vaccine and that warrants further investigation.”